Search
for
Sort by
Research 121–150 of 358
- Hair diameter vs. hair density in male androgenetic alopecia
- Hair Changes due to Drugs
- Anatomic location of primary melanoma: Survival differences and sun exposure
- Dissecting the boundary of quiescence and activation of murine melanocyte stem cells in the hair follicle niche
- Effects of local and systemic medications on eye health: Adverse reactions
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- 453 Signaling by Senescent Melanocytes Induces New Hair Growth and Informs Hair Growth-Activating Injectable for Androgenetic Alopecia
- Editor's evaluation: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Genetically modified laboratory mice with sebaceous glands abnormalities
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
- Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Targeting the (Un)differentiated State of Cancer
- FilaggrinHigh melanomas exhibit active FGFR and allergic signatures with impaired GNA14 and Th1 signatures
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Re‐Innovation in Clinical Trial Designs Based on Precision Therapy
- The Dual Nature of Cellular Senescence: From Aging Signature to Regenerative Catalyst
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Epigenetics of Colorectal Cancer
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches